The company with zero revenue that is worth $31 billion

A Wall Street stock that aims to treat neurological conditions such as ADHD and autism has made a mystifying 64,000 per cent surge without selling a single product.

​A Wall Street stock that aims to treat neurological conditions such as ADHD and autism has made a mystifying 64,000 per cent surge without selling a single product. Business / Companies Sydney Morning Herald – Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *